Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent update.

Biomed Res Int · 2013 · PMC3581271 · PMID 23484133

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In vivo inhibition of TNF by infliximab infusion resulted in a highly significant transient increase of p38 alpha activity during the first 48 h after infusion.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.